BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32149799)

  • 1. Solitary Penile Metastasis of Prostate Cancer on 18F-Fluciclovine PET/CT Imaging in a Patient With PSA of 1 ng/mL.
    Salavati A; Schik AN; Koksel Y; Gencturk M; Froelich JW
    Clin Nucl Med; 2020 May; 45(5):389-391. PubMed ID: 32149799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cavernosal Metastasis From Prostate Cancer on 18F-Fluciclovine PET/CT.
    Nguyen BD
    Clin Nucl Med; 2020 Oct; 45(10):e449-e450. PubMed ID: 32520500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Lymph Node Metastasis Detected by 68Ga-Prostate-Specific Membrane Antigen But Not 18F-Fluciclovine PET/CT in Low-Prostate-Specific Antigen Biochemical Recurrence of Prostate Cancer.
    Chaussé G; Abikhzer G; Probst S
    Clin Nucl Med; 2018 Apr; 43(4):250-251. PubMed ID: 29465489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superscan 18F-Fluciclovine PET/CT of PSA-Negative Prostate Cancer Bone Metastases.
    Chen B; Macapinlac HA; Lu Y
    Clin Nucl Med; 2019 Apr; 44(4):337-338. PubMed ID: 30688749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-Fluciclovine PET/CT Detection of Recurrent Prostate Carcinoma in Patients With Serum PSA ≤ 1 ng/mL After Definitive Primary Treatment.
    England JR; Paluch J; Ballas LK; Jadvar H
    Clin Nucl Med; 2019 Mar; 44(3):e128-e132. PubMed ID: 30589673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for
    Kim EH; Siegel BA; Teoh EJ; Andriole GL;
    Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level ≤0.5 ng/mL.
    Teyateeti A; Khan B; Teyateeti A; Chen B; Bridhikitti J; Pan T; Peng W; Macapinlac HA; Lu Y
    Nucl Med Commun; 2020 Sep; 41(9):906-915. PubMed ID: 32796479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment?
    Teyateeti A; Teyateeti A; Macapinlac HA; Lu Y
    Clin Nucl Med; 2020 Sep; 45(9):672-678. PubMed ID: 32604105
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Armstrong JM; Martin CR; Dechet C; Morton K; Evans D; Ambrose J; Maughan BL; O'Neil B; Lowrance W
    Urol Oncol; 2020 Jul; 38(7):636.e1-636.e6. PubMed ID: 32317221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of
    Wang Y; Chow DZ; Ebert E; Tajmir S; Scott JA; Palmer EL
    AJR Am J Roentgenol; 2020 Oct; 215(4):997-1001. PubMed ID: 32569513
    [No Abstract]   [Full Text] [Related]  

  • 12. PSMA-targeted Radiotracers versus
    Tan N; Oyoyo U; Bavadian N; Ferguson N; Mukkamala A; Calais J; Davenport MS
    Radiology; 2020 Jul; 296(1):44-55. PubMed ID: 32396045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual Case of Diffuse Penile Metastasis of Prostate Cancer on 68Ga PSMA PET/CT Imaging and 177Lu PSMA Posttherapy Scintigraphy.
    Vadi SK; Kumar R; Mittal BR; Parihar AS; Singh SK
    Clin Nucl Med; 2018 Apr; 43(4):276-278. PubMed ID: 29465493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental Detection of Metastatic Penile Squamous-Cell Carcinoma With Anti-1-Amino-3-F-18-Fluorocyclobutane-1-Carboxylic Acid (
    Bhanvadia RR; Woldu SL; Margulis V; Subramaniam RM; Bagrodia A
    Clin Genitourin Cancer; 2019 Feb; 17(1):e184-e186. PubMed ID: 30454969
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer.
    Savir-Baruch B; Lovrec P; Solanki AA; Adams WH; Yonover PM; Gupta G; Schuster DM
    AJR Am J Roentgenol; 2019 Oct; 213(4):851-858. PubMed ID: 31216198
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of hormonal therapy on
    Bulbul JE; Hashem A; Grybowski D; Joyce C; Rashad E; Gabriel MS; Wagner RH; Savir-Baruch B
    Urol Oncol; 2022 Aug; 40(8):379.e9-379.e16. PubMed ID: 35738974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
    Nanni C; Zanoni L; Pultrone C; Schiavina R; Brunocilla E; Lodi F; Malizia C; Ferrari M; Rigatti P; Fonti C; Martorana G; Fanti S
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1601-10. PubMed ID: 26960562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of
    Scarsbrook AF; Bottomley D; Teoh EJ; Bradley KM; Payne H; Afaq A; Bomanji J; van As N; Chua S; Hoskin P; Chambers A; Cook GJ; Warbey VS; Han S; Leung HY; Chau A; Miller MP; Gleeson FV;
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):316-324. PubMed ID: 32068113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental 18F-Fluciclovine Uptake in a Warthin Tumor of the Parotid Gland in a Patient Undergoing PET/CT Imaging for Biochemical Recurrent Prostate Cancer.
    Bitar R; Martiniova L; Bell D; Ravizzini G
    Clin Nucl Med; 2020 Apr; 45(4):e208-e210. PubMed ID: 31977491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer.
    Farkas AB; Green ED; Thaggard AL; Vijayakumar V; Henegan JC; Lirette ST; Nittala MR; Vijayakumar S
    South Med J; 2021 Nov; 114(11):703-707. PubMed ID: 34729614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.